Humacyte, Inc. (HUMA) Insider Trading
Sector: Biotechnology · Market Cap: $298M · 0 insider purchases in the last 7 days
No open market insider purchases at Humacyte, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track HUMA on your watchlist.
Start for FreeAbout Humacyte, Inc. Insider Trading
2 insiders at Humacyte, Inc. (HUMA) have purchased stock in the past 90 days, totaling $60K across 2 transactions (67,818 shares).
The most recent purchase was by Director Sebelius Kathleen on May 19, 2026 — a $50K buy of 56,818 shares at $0.88, bringing his total holdings to 148,025 shares.
Insiders who purchased: Sebelius Kathleen (Director, 1 buy totaling $50K); Constantino Michael T. (Director, 1 buy totaling $10K).
This insider buying is notable given that HUMA had no recorded open market purchases in the nine months before that.
HUMA is in the Biotechnology sector within the Biotechnology industry with a market cap of $298M.
Track HUMA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.